2024-05-06 20:11:09 ET
Hims & Hers Health, Inc. (HIMS)
Q1 2024 Earnings Conference Call
May 06, 2024, 05:00 PM ET
Company Participants
Bill Newby - Head, IR
Andrew Dudum - Co-Founder and CEO
Yemi Okupe - CFO
Conference Call Participants
Allen Lutz - Bank of America
Maria Ripps - Canaccord
Daniel Grosslight - Citi
Jack Wallace - Guggenheim Securities
Jonna Kim - TD Cowen
Aaron Kessler - Seaport Global
Glen Santangelo - Jefferies
Jailendra Singh - Truist Securities
Korinne Wolfmeyer - Piper Sandler
George Hill - Deutsche Bank
Presentation
Operator
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Hims & Hers First Quarter 2024 Earnings Conference Call. Please note that this call is being recorded. [Operator Instructions]
I would now like to turn today's call over to Bill Newby, Head of Investor Relations. Please go ahead.
Bill Newby
Good afternoon, everyone, and welcome to the Hims & Hers Health first quarter 2024 earnings call. Today, after the market closed, We released this quarter's shareholder letter, a copy of which you can find on our website at investors.hims.com.
On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; as well as Yemi Okupe, our Chief Financial Officer.
Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on, among other things, our current market, competitors and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions or otherwise. Please view our most recently filed 10-K and 10-Q reports for a discussion of risk factors as they relate to forward-looking statements.
In today's presentation, we have certain non-GAAP financial measures. We refer you to the reconciliation tables to the most directly comparable GAAP financial measures contained in today's press release and Shareholder Letter. You can find this information as well as a link to today's webcast at investors.hims.com. After the call, this webcast will be archived on the website for 12 months.
And with that, I'll now turn the call over to Andrew.
Andrew Dudum
Thanks, Bill.
Our first quarter results marked an outstanding beginning to the year. The momentum we built in 2023 is continuing. As we further advance our mission to help the world feel great through the power of better health. The underlying strength of our business is propelled by an unwavering dedication to delivering the highest quality personalized care possible across each of our five core specialties, men's and women's dermatology, mental health, sexual health and weight loss....
Read the full article on Seeking Alpha
For further details see:
Hims & Hers Health, Inc. (HIMS) Q1 2024 Earnings Call Transcript